eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
6.44
+0.24 (3.96%)
At close: Sep 18, 2026, 4:00 PM EDT
6.44
+0.01 (0.08%)
After-hours: Sep 18, 2026, 6:34 PM EDT
eXoZymes Employees
eXoZymes had 32 employees as of December 31, 2025. The number of employees increased by 1 or 3.23% compared to the previous year.
Employees
32
Change (1Y)
1
Growth (1Y)
3.23%
Revenue / Employee
n/a
Profits / Employee
-$318,465
Market Cap
59.73M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 32 | 1 | 3.23% |
| Dec 31, 2024 | 31 | 2 | 6.90% |
| Dec 31, 2023 | 29 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Heron Therapeutics | 128 |
| MindWalk Holdings | 77 |
| Xilio Therapeutics | 76 |
| INmune Bio | 21 |
| ImageneBio | 18 |
| Edesa Biotech | 17 |
| Serina Therapeutics | 16 |
| MiNK Therapeutics | 15 |
EXOZ News
- 11 days ago - eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCT - Accesswire
- 25 days ago - eXoZymes Inc trading resumes - TheFly
- 25 days ago - eXoZymes Inc trading halted, volatility trading pause - TheFly
- 4 weeks ago - eXoZymes Earnings Call Transcript: Q2 2026 - Transcripts
- 4 weeks ago - eXoZymes Quarterly report: Q2 2026 - Filings
- 4 weeks ago - eXoZymes Earnings release: Q2 2026 - Filings
- 4 weeks ago - eXoZymes Reports Second Quarter 2026 Results and Provides Business Update at 5PM ET Today - Accesswire
- 4 weeks ago - eXoZymes' NCT Process Achieves 10-fold Productivity Increase, Advancing Beyond Original Commercial-scale Economic Targets - Accesswire